Daniel C. Baumgart MD, PhD, MBA, FRCP, AGAF

Dr. Daniel C. Baumgart, MD, Ph.D., MBA, FRCP, AGAF went to medical school in Berlin, Basle (Switzerland) and Wurzburg (Bavaria). He received his training in internal medicine, gastroenterology, hepatology, and immunology at the Charite and as a German Academic Exchange Service (DAAD) and German Research Council (DFG) scholar at the University of Pennsylvania, Philadelphia, PA, USA, Georgetown University, Washington, DC, USA, Lombardi Cancer Center, National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) Bethesda, MD, USA, Inova Fairfax Hospital Fairfax, VA, USA, Virginia Hospital Center, Arlington, VA, USA as well as US Public Health Service and Veterans Affairs Medical Center in Washington, DC, USA and holds an unrestricted license to practice medicine and surgery in the US and Germany.

Dr. Baumgart is currently Professor of Gastroenterology and Hepatology and Director, Division of Gastroenterology, AHS Zone Head and Director of the Inflammatory Bowel Disease Program at the University of Alberta in Edmonton, Canada. He is also Visiting Professor at Peking University, Beijing China and was Visiting Professor at Yale University, New Haven, CT and Harvard University, Boston, MA, USA. He is involved in the development and evaluation of novel concepts for Crohn’s disease and ulcerative colitis including optical detection to visualize inflammation, mucosal damage, and epithelial restitution and image-guided intervention. He has been the principal investigator in some 200 multinational clinical trials. A trailblazer of digitization he has a strong interest in artificial intelligence (AI) and digital health to provide precision medicine at the point of care. His laboratory is focused on innate and adaptive immunity and the microbiome. Dr. Baumgart’s work has appeared in leading publications including The Lancet, Gut and Inflammatory Bowel Diseases. He serves on numerous national and international expert and guideline panels.